Retail Earnings, Pharma Price Wars, and Japanese Stock Strategies (August 18, 2025)

In this episode of Wall Street Beats, hosts Steve Lamar and David Maris dive into a busy week on Wall Street. They discuss the latest retail earnings from giants like Target and Walmart, analyze the ongoing price battles in the pharmaceutical sector—especially between Novo and Lilly—and break down the implications for investors. David shares his approach to building a portfolio of Japanese stocks to hedge against a weakening dollar, including his research process and what to watch out for. The conversation also covers HIMSS’s recent performance, the challenges of telemedicine business models, and practical advice for investors of all portfolio sizes. Tune in for actionable insights and a candid look at the week ahead in the markets.
Subscribe to get more stock analysis and insights from the Beats Roundtable pros.

Want more? Become a member. Join the Inner Circle and get a Seat at the Roundtable now: https://www.passes.com/wallst-beats for exclusive access to our pros.

Disclaimer
This content has been produced by Street Beats Media, LLC (“Street Beats”) and is presented for informational purposes only. Street Beats is not a broker dealer and does not provide investment advice to individuals. None of the information contained herein constitutes an offer to sell, or solicitation of an offer to buy any security or investment vehicle, nor does it constitute an investment recommendation or legal, tax, accounting, or investment advice by Street Beats or any of its employees, officers, or agents. This information is presented without regard for individual investment preferences or risk parameters and is general, non-tailored, non-specific information. Our content is based on information from the sources believed to be reliable. Street Beats is not responsible for errors, inaccuracies, or omissions of information. The opinions and conclusions contained in this content are those of the individual expressing those opinions or conclusions and are intended solely for the use by Street Beats subscribers and the authorized recipients on the content.

All investments involve a certain degree of risk and financial instrument prices can fluctuate based on several factors, including those not considered in the preparation of this content. Consult a financial professional before investing.